AUTHOR=Rasyid Al , Pemila Uke , Aisah Siti , Harris Salim , Wiyarta Elvan , Fisher Marc 

TITLE=Exploring the self-efficacy and self-care-based stroke care model for risk factor modification in mild-to-moderate stroke patients

JOURNAL=Frontiers in Neurology

VOLUME=Volume 14 - 2023

YEAR=2023

URL=https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2023.1177083

DOI=10.3389/fneur.2023.1177083

ISSN=1664-2295

ABSTRACT=<sec><title>Context</title><p>The worldwide burden of stroke is projected to grow unless proper stroke education is implemented. Information alone cannot promote patient self-efficacy and self-care and reduce risk factors.</p></sec><sec><title>Aim</title><p>This trial aimed to test self-efficacy and self-care-based stroke education (SSE) on changes in self-efficacy, self-care, and risk factor modification.</p></sec><sec><title>Design, setting, and participants</title><p>This study is a single-center, double-blinded, interventional, two-arm randomized controlled trial with a 1- and 3-month follow-up in Indonesia. Between January 2022 and October 2022, 120 patients were prospectively enrolled from Cipto Mangunkusumo National Hospital, Indonesia. Participants were assigned using a computer-generated random number list.</p></sec><sec><title>Intervention</title><p>SSE was given before discharge from the hospital.</p></sec><sec><title>Primary outcome measure</title><p>Self-care, self-efficacy, and stroke risk score was measured 1 month and 3 months after discharge.</p></sec><sec><title>Secondary outcome measure</title><p>Modified Rankin Scale, Barthel Index, and blood viscosity was measured at 1 month and 3 months after discharge.</p></sec><sec><title>Results</title><p>A total of 120 patients (intervention <italic>n</italic> = 60; standard care <italic>n</italic> = 60) were randomized. In the 1st month, the intervention group showed a more significant change in self-care (4.56 [95% CI: 0.57, 8.56]), self-efficacy (4.95 [95% CI: 0.84, 9.06]), and stroke risk (−2.33 [95% CI:−3.19, −1.47]) compared to the controlled group. In the 3rd month, the intervention group also showed a more significant change in self-care (19.28 [95% CI: 16.01, 22.56]), self-efficacy (19.95 [95% CI: 16.61, 23.28]), and stroke risk (−3.83 [95% CI: −4.65, −3.01]) compared to the controlled group.</p></sec><sec><title>Conclusion</title><p>SSE may boost self-care and self-efficacy, adjust risk factors, enhance functional outcomes, and decrease blood viscosity.</p></sec><sec><title>Clinical trial registration</title><p><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/ISRCTN11495822" xmlns:xlink="http://www.w3.org/1999/xlink">ISRCTN11495822</ext-link>.</p></sec>